跳至主要内容
临床试验/NCT05424939
NCT05424939Unknown不适用

Management of Obstructive Colon Tumors in Istanbul: Multicenter Prospective Observational Cohort

Istanbul Medipol University Hospital2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Time-to-starting chemotherapy

研究概览

简要总结

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
  • Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT

排除标准

  • Benign diseases
  • Emergency surgery due to bleeding, perforation and other non-obstructive situations
  • Recurrent colon tumors
  • Rectal cancer

结局指标

主要结局

Time-to-starting chemotherapy

时间窗: 1 year

Surgical procedures will be compared in terms of days-to-first chemotherapy

次要结局

  • Morbidity(3 months)
  • Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year(1 year)
  • Mortality(3 months)

研究者

发起方
Istanbul Medipol University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Management of Obstructive Colon Tumors in Istanbul | 临床试验